Stijn Koolen - Erasmus MC | 人才画像

基本信息

浏览量：39

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 205 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Pseudo Acute Kidney Injury in Patients Receiving CDK4/6 Inhibitors

Sanne M. Buijs, Elisabeth M. Jongbloed, Lotte E. M. van Bergen, Christian R. B. Ramakers,Stijn L. W. Koolen,Ron H. J. Mathijssen,Michiel G. H. Betjes,Agnes Jager

BRITISH JOURNAL OF CANCER (2025)

引用0浏览0WOSNATURE引用

First Real-World Clinical Experience with [177Lu]lu-Psma-i&t in Patients with Metastatic Castration-Resistant Prostate Cancer Beyond VISION and TheraP Criteria

Sui wai Ling, Quido de Lussanet de la Sablonière, Michael Ananta,Erik de Blois,Stijn L. W. Koolen, Roosmarijn C. Drexhage,Johannes Hofland, Debbie G. J. Robbrecht, Astrid A M van der Veldt, Frederik A Verburg,Tessa Brabander

European Journal of Nuclear Medicine and Molecular Imagingpp.1-7, (2025)

引用0浏览0WOS引用

Implementation of Model-Informed Precision Dosing for Tamoxifen Therapy in Patients with Breast Cancer: A Prospective Intervention Study

Ruben Y. M. van Nijnatten,Sanne M. Buijs,Bram C. Agema, Raphael M. J. Fischer, Inge Ghobadi Moghaddam-Helmantel, Caroline M. E. Contant, Felix E. de Jongh, Auke M. T. Huijben, Manon Kop, Annemieke van der Padt-pruijsten,Hanneke J. M. Zuetenhorst,Ron H. N. van Schaik,Birgit C. P. Koch,A. Jager,Stijn L. W. Koolen,Ron H. J. Mathijssen

BREAST (2025)

引用0浏览0WOS引用

Population Pharmacokinetics of Cobicistat and Its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib

Joanneke K. Overbeek,Nielka P. van Erp,David M. Burger, Alfons A. den Broeder,Stijn L. W. Koolen,Alwin D. R. Huitema,Rob ter Heine

Clinical Pharmacokinetics（2025）

引用0浏览0WOS引用

Population Pharmacokinetics of Intraperitoneal Irinotecan and SN‐38 in Patients with Peritoneal Metastases from Colorectal Origin

Pascale C. S. Rietveld,Sebastiaan D. T. Sassen,Niels A. D. Guchelaar,Ruben A. G. van Eerden,Nadine L. de Boer,Teun B. M. van den Heuvel,Jacobus W. A. Burger,Ron H. J. Mathijssen,Birgit C. P. Koch,Stijn L. W. Koolen

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYno. 6 (2024): 1006-1016

引用0浏览0WOS引用

Sunitinib for the Treatment of Metastatic Gastrointestinal Stromal Tumors: the Effect of TDM-guided Dose Optimization on Clinical Outcomes

E. L. Giraud,K. Westerdijk, M. B. A. van der Kleij, N. A. D. Guchelaar,M. Meertens,R. F. Bleckman, A. Rieborn,M. Mohammadi, E. Roets,R. H. J. Mathijssen,A. D. R. Huitema,S. L. W. Koolen,H. Gelderblom,D. J. A. R. Moes,A. K. L. Reyners,D. J. Touw, P. Keizer-Heldens,A. W. Oosten,W. T. A. van der Graaf,N. Steeghs,N. P. van Erp,I. M. E. Desar

ESMO Openno. 6 (2024): 103477-103477

引用0浏览0WOS引用

Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails

Niels A. D. Guchelaar,Maud B. A. van Der Kleij,Neeltje Steeghs,Alwin D. R. Huitema,Ron H. J. Mathijssen,Stijn L. W. Koolen

CLINICAL PHARMACOLOGY & THERAPEUTICS (2024)

引用0浏览0WOS引用

Data from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer Through Cell Cycle Arrest at the G<sub>1</sub>–S Transition

Stefan A. J. Buck,Annelies Van Hemelryk,Corrina de Ridder,Debra Stuurman,Sigrun Erkens-Schulze,Sem van't Geloof,Wilma J. Teubel,Stijn L. W. Koolen,Elena S. Martens-Uzunova,Martin E. van Royen,Ronald de Wit,Ron H. J. Mathijssen,Wytske M. van Weerden

MOLECULAR CANCER THERAPEUTICSno. 5 (2024): 711-720

引用2浏览0WOS引用

Figure S6 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer Through Cell Cycle Arrest at the G<sub>1</sub>–S Transition

Stefan A.J. Buck,Annelies Van Hemelryk,Corrina de Ridder,Debra Stuurman,Sigrun Erkens-Schulze,Sem van ’t Geloof,Wilma J. Teubel,Stijn L.W. Koolen,Elena S. Martens-Uzunova,Martin E. van Royen,Ronald de Wit,Ron H.J. Mathijssen,Wytske M. van Weerden

crossref（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn